Evidence map›Paper›PMID 18193449›Full record

ReviewHistochemistry and cell biology2008

Clathrin-independent endocytosis: from nonexisting to an extreme degree of complexity.

Kirsten Sandvig, Maria Lyngaas Torgersen, Hilde Andersen Raa, Bo van Deurs

Abstract readReview
In one paragraph

Review in Histochemistry and cell biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Nanoparticle-Plant Interactions: Two-Way Traffic.Small (Weinheim an der Bergstrasse, Germany) · 2019
    Review
  13. Article
  14. Article
  15. The LTBJournal of cell science · 2018
    Article
  16. Review
  17. In focus in HCB.Histochemistry and cell biology · 2018
    Article
  18. Article
  19. Review
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kirsten SandvigCentre for Cancer Biomedicine, University of Oslo and Department of Biochemistry, The Norwegian Radium Hospital, Montebello, Oslo, Norway. ksandvig@radium.uio.no
Maria Lyngaas Torgersen
Hilde Andersen Raa
Bo van Deurs

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Today it is generally accepted that there are several endocytic mechanisms, both the clathrin-dependent one and mechanisms which operate without clathrin and with different requirements when it comes to dynamin, small GTP-binding proteins of the Rho family and specific lipids. It should be noted that clathrin-independent endocytosis can occur even when the cholesterol level in the membrane has been reduced to so low levels that caveolae are gone and clathrin-coated membrane areas are flat. Although new investigators in the field take it for granted that there is a multitude of entry mechanisms, it has taken a long time for this to become accepted. However, more work needs to be done, because one can still ask the question: How many endocytic mechanisms does a cell have, what are their function, and how are they regulated? This article describes some of the history of endocytosis research and attempts to give an overview of the complexity of the mechanisms and their regulation.

Indexed as

ActinsADP-Ribosylation FactorsAnimalsCaveolaeClathrinEndocytosisEpithelial CellsHumansMembrane LipidsPinocytosisrho GTP-Binding ProteinsActinsADP-Ribosylation FactorsClathrinMembrane Lipidsrho GTP-Binding Proteins

Identifiers

PMID18193449
PMCPMC2248609

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.